How do tertiary lymphoid structures influence immunotherapy outcomes in Merkel cell carcinoma? Spatial proteomics reveals key ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

The U.S. has a new lightning champion. Oklahoma has dethroned Florida to become the nation's lightning capital, according to ...

A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's immune system to target and eliminate cancer cells appeared to reduce the ...

Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall ...

Former German Chancellor Angela Merkel is making unexpected enemies and unlikely friends as she speaks candidly about her time in office while touring for her latest book. Speaking with Hungarian ...

Merkel cell polyomavirus is one of seven viruses known to cause cancer in humans. Infection with this virus is asymptomatic, but, rarely, it can lead to the development of Merkel cell carcinoma (MCC), ...

In a prospective study of patients with stages I-III Merkel cell carcinoma (MCC), seropositivity for rising polyomavirus oncoprotein antibody titers conferred a 58% risk for recurrence at 12 months, ...

Please provide your email address to receive an email when new articles are posted on . Merkel cell carcinoma is often diagnosed after metastasis to other organs. However, new findings show those with ...

SPOKANE, Wash. — Drivers in Northwest Spokane should expect some delays and might need to change their commute starting Tuesday morning due to construction. According to the City of Spokane, ...

TuHURA Biosciences advances its phase 3 trial of IFx-2.0 for Merkel cell carcinoma, aiming to enhance immune response alongside pembrolizumab. The FDA has lifted a partial clinical hold related to ...